1-(4-Chlorophenyl)-N-(2-ethoxyphenyl)-6-methyl-4-oxo-1,4-dihydropyridazine-3-carboxamide
98%
- Product Code: 156733
CAS:
869875-89-8
| Molecular Weight: | 383.83 g./mol | Molecular Formula: | C₂₀H₁₈ClN₃O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | 1.28±0.1 g/cm3(Predicted) | Storage Condition: | -20°C, Sealed, Dry |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of anti-inflammatory and analgesic compounds. Its structure supports binding to enzyme targets involved in pain and inflammation pathways. Employed in research settings to design new cyclooxygenase (COX) inhibitors with improved selectivity. Also utilized in structure-activity relationship (SAR) studies to optimize potency and reduce side effects in nonsteroidal anti-inflammatory drugs (NSAIDs). Shows potential in medicinal chemistry for developing derivatives with enhanced bioavailability and metabolic stability.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1mg | 10-20 days | $141.63 |
+
-
|
| 5mg | 10-20 days | $495.51 |
+
-
|
| 10mg | 10-20 days | $743.04 |
+
-
|
1-(4-Chlorophenyl)-N-(2-ethoxyphenyl)-6-methyl-4-oxo-1,4-dihydropyridazine-3-carboxamide
Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of anti-inflammatory and analgesic compounds. Its structure supports binding to enzyme targets involved in pain and inflammation pathways. Employed in research settings to design new cyclooxygenase (COX) inhibitors with improved selectivity. Also utilized in structure-activity relationship (SAR) studies to optimize potency and reduce side effects in nonsteroidal anti-inflammatory drugs (NSAIDs). Shows potential in medicinal chemistry for developing derivatives with enhanced bioavailability and metabolic stability.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :